Fermenta Biotech Reports 57% Revenue Growth and 664% Net Profit Surge in H1 FY26

Fermenta Biotech Ltd has reported exceptional financial performance for the first half of fiscal year 2026, demonstrating significant growth across key metrics.

Key Financial Highlights for H1 FY26

Metric	H1 FY26	YoY Change
Revenue	₹280.70 crore	+57%
Net Profit	₹39.60 crore	+664%
EBITDA	₹69.10 crore	+173%

Revenue and Profit Surge

Fermenta Biotech has reported a substantial increase in its consolidated revenue for the first half of FY26, reaching ₹280.70 crore, representing a 57% year-over-year growth. The company's net profit saw an extraordinary surge of 664% year-over-year, climbing to ₹39.60 crore.

Segment Performance

Human Nutrition Segment

Revenue: ₹158.80 crore (+80% YoY)
Volume growth: 74%

Animal Nutrition Segment

Revenue: ₹46.20 crore (+44% YoY)
Volume growth: 6%
Average realizations: +35%

German Subsidiary

Revenue: ₹34.30 crore (+194% YoY)

Strategic Developments

Fermenta Biotech received a patent for its proprietary plant-based Vitamin D3 manufacturing process.
The company transferred its Environment Division to a wholly-owned subsidiary for ₹19.00 crore.

Management Commentary

Managing Director Prashant Nagre noted that the H1 FY26 revenue already represents 64.5% of the full FY25 revenue, confirming the company's turnaround trajectory.

EBITDA Performance

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) for H1 FY26 rose to ₹69.10 crore, reflecting a substantial 173% increase year-over-year. This significant growth in EBITDA indicates improved operational efficiency and strong cost management.

Conclusion

Fermenta Biotech's H1 FY26 results demonstrate the company's ability to drive significant growth across all key financial metrics. The substantial increases in revenue, net profit, and EBITDA highlight the effectiveness of the company's business model and its strong market position. The growth in both human and animal nutrition segments, coupled with the exceptional performance of its German subsidiary, underscores the company's successful diversification strategy.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+6.54%	+0.26%	-3.42%	+6.68%	-11.86%	-7.77%

Fermenta Biotech Limited has made a strategic move by investing an additional Rs 7.9 crore in its wholly-owned subsidiary, Fermenta Environment Solutions Private Limited (FESPL). This investment comes as part of the company's efforts to bolster its presence in the environmental solutions sector.

Investment Details

Aspect	Details
Investment Amount	Rs 7.9 crore
Mode of Investment	Rights Issue
Shares Allotted	79 lakh equity shares
Share Face Value	Rs 10 each

About Fermenta Environment Solutions Private Limited

FESPL operates in the environment industry with a focus on sustainable solutions. The subsidiary specializes in:

Conceiving and designing environmental solutions
Providing and fabricating sustainable systems
Constructing and manufacturing eco-friendly solutions
Waste management initiatives

Purpose of Investment

The infusion of funds is intended to support FESPL's operations in two key areas:

Working capital management
Other business-related expenditures

This move suggests Fermenta Biotech's commitment to strengthening its foothold in the environmental solutions market.

Transaction Classification

The investment has been classified as a related party transaction. However, it's important to note that:

The transaction was conducted at arm's length
There is no change in Fermenta Biotech's ownership percentage in FESPL

This investment underscores Fermenta Biotech's strategy to enhance its subsidiary's capabilities in providing sustainable environmental solutions, potentially positioning the company to capitalize on the increasing demand for eco-friendly technologies and waste management systems.